Cholangiopathy as part of post-COVID syndrome

Manuel Rojas; Yhojan Rodríguez; Elizabeth Zapata; Juan Carlos Hernández; Juan-Manuel Anaya

doi:10.1016/j.jtauto.2021.100116

Cholangiopathy as part of post-COVID syndrome

Manuel Rojas, Yhojan Rodríguez, Elizabeth Zapata, Juan Carlos Hernández, Juan-Manuel Anaya

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this condition in patients with COVID-19.

Original language	English (US)
Article number	100116
Pages (from-to)	1-3
Number of pages	3
Journal	Journal of Translational Autoimmunity
Volume	4
Early online date	Aug 31 2021
DOIs	https://doi.org/10.1016/j.jtauto.2021.100116
State	Published - 2021

All Science Journal Classification (ASJC) codes

Infectious Diseases

Access to Document

10.1016/j.jtauto.2021.100116

Cite this

@article{a77c265109574753a68bec7646e5b8b0,

title = "Cholangiopathy as part of post-COVID syndrome",

abstract = "Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this condition in patients with COVID-19.",

author = "Manuel Rojas and Yhojan Rodr{\'i}guez and Elizabeth Zapata and Hern{\'a}ndez, {Juan Carlos} and Juan-Manuel Anaya",

note = "{\textcopyright} 2021 The Authors.",

year = "2021",

doi = "10.1016/j.jtauto.2021.100116",

language = "English (US)",

volume = "4",

pages = "1--3",

journal = "Journal of Translational Autoimmunity",

issn = "2589-9090",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Cholangiopathy as part of post-COVID syndrome

AU - Rojas, Manuel

AU - Rodríguez, Yhojan

AU - Zapata, Elizabeth

AU - Hernández, Juan Carlos

AU - Anaya, Juan-Manuel

PY - 2021

Y1 - 2021

N2 - Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this condition in patients with COVID-19.

AB - Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this condition in patients with COVID-19.

U2 - 10.1016/j.jtauto.2021.100116

DO - 10.1016/j.jtauto.2021.100116

M3 - Article

C2 - 34485887

SN - 2589-9090

VL - 4

SP - 1

EP - 3

JO - Journal of Translational Autoimmunity

JF - Journal of Translational Autoimmunity

M1 - 100116

ER -

Cholangiopathy as part of post-COVID syndrome

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Fingerprint

Cite this